Skip to main content
Jeffrey Goldberg, MD, Ophthalmology, Stanford, CA

JeffreyLouisGoldbergMDPhD

Ophthalmology Stanford, CA

Cataract Related, Glaucoma Related

Professor and Chair, Ophthalmology, Byers Eye Institute at Stanford University

Dr. Goldberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Goldberg's full profile

Already have an account?

  • Office

    300 Pasteur Dr
    Stanford, CA 94305
    Phone+1 650-723-4000

Summary

  • Dr. Jeffrey Goldberg is Professor and Chair of Ophthalmology at the Byers Eye Institute at Stanford University. His clinical effort is focused on patients in need of medical or surgical intervention for glaucoma and other retinal and optic nerve diseases, as well as cataract. His research is directed at neuroprotection and regeneration of retinal ganglion cells and the optic nerve, a major unmet need in glaucoma and other optic neuropathies, and his laboratory is developing novel stem cell and nanotherapeutics approaches for eye repair.

    Dr. Goldberg received his B.S. magna cum laude from Yale University, and his M.D. and Ph.D. from Stanford University where he made significant discoveries about the failure of optic nerve regeneration. He did his clinical training in ophthalmology and then in glaucoma at the Bascom Palmer Eye Institute, and was awarded a fellowship from the Heed Foundation. He was named the 2010 Scientist of the Year by the Hope For Vision foundation, and received the Cogan award from the Association for Research in Vision and Ophthalmology in 2012. He was elected in 2010 to the American Society of Clinical Investigation, an honorary society of physician scientists. He directs an NIH-funded research laboratory and has developed significant expertise with implementing FDA IND clinical trials for optic nerve neuroprotection and regeneration. His goal is to translate scientific discoveries to patient therapies.

Education & Training

  • University of Miami Hospital and Clinics
    University of Miami Hospital and ClinicsFellowship, Glaucoma, 2009 - 2010
  • University of Miami/Jackson Health System/Bascom Palmer Eye Institute
    University of Miami/Jackson Health System/Bascom Palmer Eye InstituteResidency, Ophthalmology, 2005 - 2008
  • Santa Clara Valley Medical Center
    Santa Clara Valley Medical CenterInternship, Transitional Year, 2003 - 2004
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 2003
  • Yale University
    Yale UniversityBS, Biology, 1990 - 1994

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2012 - 2026
  • FL State Medical License
    FL State Medical License 2008 - 2014
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Member American Glaucoma Society
  • Member Society for Neuroscience
  • Elected Member The American Society for Clinical Investigation, 2011
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The Krüppel-like Factor Gene Target Dusp14 Regulates Axon Growth and Regeneration  
    Jeffrey L Goldberg, Akintomide Apara, Investigative Ophthalmology and Visual Science

Press Mentions

  • Emmecell Completes Last Patient Last Visit for Proof-of-Concept Trial of Groundbreaking Cell Therapy for Corneal Edema
    Emmecell Completes Last Patient Last Visit for Proof-of-Concept Trial of Groundbreaking Cell Therapy for Corneal EdemaOctober 8th, 2024
  • National Academy of Medicine Honors CIRM Grantees
    National Academy of Medicine Honors CIRM GranteesSeptember 3rd, 2021
  • BioLight Invests in US Peripheral Vision Home Test Co
    BioLight Invests in US Peripheral Vision Home Test CoJuly 28th, 2021
  • Join now to see all

Grant Support

  • Signaling Scaffolds And Survival In StrokeNational Eye Institute2012
  • Triazine-Based Compounds To Promote Regeneration In Optic NeuropathiesNational Institute Of Neurological Disorders And Stroke2011
  • Kruppel-Like Transcription Factors In Retinal Ganglion Cell RegenerationNational Eye Institute2010–2011
  • Retinal Scaffolds: Synaptic And Stem Cell IntegrationNational Eye Institute2009–2010
  • Developmental Control Of Axon Regeneration In RgcsNational Institute Of Neurological Disorders And Stroke2007–2010
  • Magnetic Nanoparticles For Trophic Stimulation And Axon RegenerationNational Eye Institute2007–2009
  • Intrinsic Molecular Control Of Axon Regeneration In RgcsNational Eye Institute2005–2007

Professional Memberships